EP2015803A4 - Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances - Google Patents

Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Info

Publication number
EP2015803A4
EP2015803A4 EP07835752A EP07835752A EP2015803A4 EP 2015803 A4 EP2015803 A4 EP 2015803A4 EP 07835752 A EP07835752 A EP 07835752A EP 07835752 A EP07835752 A EP 07835752A EP 2015803 A4 EP2015803 A4 EP 2015803A4
Authority
EP
European Patent Office
Prior art keywords
aspeeries
nanofibres
sequester
wear
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07835752A
Other languages
German (de)
English (en)
Other versions
EP2015803A2 (fr
Inventor
Darrell H Reneker
Daniel J Smith
David Barrett Meyers
Nevenka Golubovic-Liakopoulos
Alexander Marin
Alexander K Andrianov
Peter G Carroll
Sanford R Simon
Tao Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Akron
Apogee Technology Inc
Original Assignee
University of Akron
Apogee Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Akron, Apogee Technology Inc filed Critical University of Akron
Publication of EP2015803A2 publication Critical patent/EP2015803A2/fr
Publication of EP2015803A4 publication Critical patent/EP2015803A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
EP07835752A 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances Withdrawn EP2015803A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US79892806P 2006-05-09 2006-05-09
US84850506P 2006-09-29 2006-09-29
US84850706P 2006-09-29 2006-09-29
US84821306P 2006-09-29 2006-09-29
US84850406P 2006-09-29 2006-09-29
US84850606P 2006-09-29 2006-09-29
PCT/US2007/011228 WO2008024141A2 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Publications (2)

Publication Number Publication Date
EP2015803A2 EP2015803A2 (fr) 2009-01-21
EP2015803A4 true EP2015803A4 (fr) 2009-05-06

Family

ID=39107260

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07835752A Withdrawn EP2015803A4 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Country Status (4)

Country Link
EP (1) EP2015803A4 (fr)
AU (1) AU2007288442A1 (fr)
CA (1) CA2650197A1 (fr)
WO (1) WO2008024141A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
EP2146689B1 (fr) 2007-04-16 2020-08-12 Corium, Inc. Réseaux de micro-aiguilles coulées dans un solvant contenant un actif
US20110213335A1 (en) * 2008-11-18 2011-09-01 Burton Scott A Hollow microneedle array and method
AU2015271878B2 (en) * 2010-04-28 2017-05-11 Sorrento Therapeutics, Inc. Device for delivery of rheumatoid arthritis medication
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
RU2585159C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Устройство доставки лекарственного средства, применяемого при ревматоидном артрите
MX346337B (es) 2010-04-28 2017-03-14 Kimberly Clark Co Dispositivo médico con nanopatrón con interacción celular mejorada.
CN102985131B (zh) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 用于递送siRNA的医疗装置
WO2011140274A2 (fr) 2010-05-04 2011-11-10 Corium International, Inc. Méthode et dispositif permettant l'administration transdermique d'hormone parathyroïdienne au moyen d'un réseau de microprojections
WO2012130193A1 (fr) * 2011-03-31 2012-10-04 Zentiva, K.S. Complexes solubles non covalents de tériparatide contenant des polysaccharides et forme pharmaceutique de tériparatide pour administration orale
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
KR20220051429A (ko) 2011-10-27 2022-04-26 소렌토 쎄라퓨틱스, 인코포레이티드 고점도 생체활성 제제의 경피 전달 방법
ES2908653T3 (es) 2011-10-27 2022-05-03 Sorrento Therapeutics Inc Dispositivos implantables para la administración de agentes bioactivos
WO2013086731A1 (fr) * 2011-12-16 2013-06-20 London Metropolitan University (Lmu) Appareil d'amenée
BR102012031954A2 (pt) * 2012-12-14 2015-01-20 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras com subtância ativa para aplicação cosmética de liberação controlada obtidas por eletrofiação e processo
BR102012031955A2 (pt) * 2012-12-14 2014-10-07 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras contendo substância ativa com liberação controlada para aplicação odontológica e processo
KR102265808B1 (ko) 2012-12-21 2021-06-16 코리움, 인크. 치료제의 전달을 위한 마이크로어레이 및 그것의 사용방법
CA2903748C (fr) 2013-03-12 2021-11-02 Corium International, Inc. Applicateurs de microprojection
WO2014151654A1 (fr) 2013-03-15 2014-09-25 Corium International, Inc. Microréseau pour l'administration d'un agent thérapeutique et ses procédés d'utilisation
AU2014237357B2 (en) 2013-03-15 2019-11-28 Corium Pharma Solutions, Inc. Multiple impact microprojection applicators and methods of use
CA2903763C (fr) 2013-03-15 2021-11-16 Corium International, Inc. Micro-reseau ayant des microstructures sans polymere, procedes de fabrication et procedes d'utilisation
EP2968119B1 (fr) 2013-03-15 2019-09-18 Corium International, Inc. Micro-réseau pour administrer un agent thérapeutique, procédés d'utilisation et procédés de fabrication
KR101527469B1 (ko) * 2013-11-04 2015-06-11 연세대학교 산학협력단 다양한 삼차원 구조를 갖는 다공성 섬유 마이크로 구조체의 제조방법
EP3188714A1 (fr) 2014-09-04 2017-07-12 Corium International, Inc. Matrice de microstructures, procédé de production et procédés d'utilisation
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11040103B2 (en) * 2016-04-15 2021-06-22 Admbioscience Inc. Method for manufacturing nucleic acid film and apparatus for injecting medicine using nucleic acid film
KR102592782B1 (ko) 2017-01-23 2023-10-20 에이에프와이엑스 테라퓨틱스 에스에이 전기방사 섬유에 기반한 2층 제품의 제조 방법
DE102017112573A1 (de) * 2017-06-07 2018-12-13 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation von Glukagon-ähnlichen-Peptid Analoga
EP4041190A1 (fr) * 2019-10-08 2022-08-17 Afyx Therapeutics A/S Compositions destinée à l'administration de protéines
WO2021157688A1 (fr) * 2020-02-07 2021-08-12 花王株式会社 Composition pour la peau à usage externe
WO2025024593A2 (fr) * 2023-07-25 2025-01-30 The Board Of Trustees Of The Leland Stanford Junior University Appareils et procédés faisant intervenir des fibres bioélectroniques à haute densité

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
WO2006027780A2 (fr) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
WO2006027780A2 (fr) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Also Published As

Publication number Publication date
WO2008024141A8 (fr) 2009-07-09
CA2650197A1 (fr) 2008-02-28
WO2008024141A2 (fr) 2008-02-28
WO2008024141A3 (fr) 2008-04-24
AU2007288442A1 (en) 2008-02-28
EP2015803A2 (fr) 2009-01-21

Similar Documents

Publication Publication Date Title
EP2015803A4 (fr) Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances
EP1999317A4 (fr) Ensemble d'usure
BRPI0815277A2 (pt) "monitores de particulado"
EP1999654A4 (fr) Propagation de la pertinence de documents étiquetés à des documents non étiquetés
BRPI0714539A2 (pt) "formas farmacêuticas"
EP2366785A4 (fr) Dérivé d'oligonucléotide, agent de marquage et utilisation de l'agent de marquage
BRPI0809787A2 (pt) "respirador isento de manutenção"
DK2010159T3 (da) Paracetamoltabletter med hurtig frigivelse
EP2340494A4 (fr) Partage sur un clic d'instantanés et de documents associés
BRPI0815430A2 (pt) "quantificação de amamentação"
DK2077729T3 (da) Orale probiotiske doseringsformer
BRPI0720333A2 (pt) "conexão de tubulação, conexão de tubulação roscada e mancal estampado"
EP2248091A4 (fr) Publicités ciblées sur des communautés
DE602007007073D1 (de) Rad- und bremsanordnungen
EP2297585A4 (fr) Détection de l' usage de cannabis
FR2898636B1 (fr) Structure de queue-d'aronde de soufflante.
DE602006018399D1 (de) Kegelrollenlager
EP2142216A4 (fr) Formulations de particule et utilisations de celles-ci
EP2139677A4 (fr) Améliorations concernant des nanocomposite et les surfaces de ceux-ci
EP1991691A4 (fr) Détection des facteurs de pathogénicité de l'anthrax
PL2839836T3 (pl) Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego
EP2323840A4 (fr) Améliorations dans des rouleaux d'ondulation
DE502008001462D1 (de) Schrägrollenlager
DE502007006015D1 (de) Wälzlager
BRPI0921302A2 (pt) clínquer, processos para fabricar um clínquer e para reduzir a aptidão de um clínquer à produção de poeira, produto e utilização de um produto.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081025

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20090408

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090708